A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Kura Oncology, Inc.
Kura Oncology, Inc.
Adela, Inc
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Tempus AI
Bristol-Myers Squibb
Gilead Sciences
Novartis
Celgene
Acrotech Biopharma Inc.
Cellerant Therapeutics
Enzon Pharmaceuticals, Inc.
MedImmune LLC